Articles tagged "Prognosis"

2021 American Transplant Congress
Living Donor Liver Transplant for Unresectable Colorectal Metastasis: A Case Series
B. Emmanuel, H. Al-Harakeh, A. Humar, C. Hughes, A. Tevar, M. Molinari, A. Ganoza
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: Colorectal Cancer (CRC) represents the third most common malignancy worldwide. In the US, CRC lifetime risk is approximately 1 in 23 (4.4%) for men…
2021 American Transplant Congress
Home-based Liver Frailty Intervention (lift) in Liver Transplant Candidates: A Pilot Study
A. J. Thuluvath¹, K. Belfanti¹, S. Morrissey¹, O. Siddiqui¹, J. Peipert¹, A. Daud¹, J. Levitsky¹, T. Bogg², A. Flores¹, D. P. Ladner¹
¹Northwestern University Transplant Research Collaborative, Chicago, IL, ²Department of Psychology, Wayne State University, Detroit, MI
*Purpose: Frailty is highly prevalent in patients awaiting LT and is associated with increased waitlist and post-transplant mortality, hospitalizations and LOS. While reduction of frailty…
2021 American Transplant Congress
Racial and Sexual Disparities in Solid Organ Transplant Outcomes Since Implementation of the Affordable Care Act Insurance Expansion Across Some States
H. Mohamed¹, C. Conceicao², A. Kumar¹, J. Buggs³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Achieving solid organ transplantation traditionally requires access to health insurance. As such, women and people of color have faced barriers to obtaining solid-organ transplants.…
2020 American Transplant Congress
Multidimensional System to Dynamically Predict Graft Survival after Kidney Transplantation
M. Raynaud¹, O. Aubert¹, S. Jordan², M. Stegall³, J. Friedewald⁴, D. Glotz¹, C. Legendre¹, D. Segev⁵, C. Lefaucheur¹, A. Loupy, On behalf of the study NCT03474003¹
¹Paris Transplant Group, Paris, France, ²Cedars Sinai, Los Angeles, CA, ³Mayo Clinic, Rochester, MN, ⁴Northwestern University, Chicago, IL, ⁵Johns Hopkins, Baltimore, MD
*Purpose: Current prediction systems of kidney-graft loss do not integrate the dynamic effect of parameters assessed over the time course of kidney recipients. Recent dynamic…
2020 American Transplant Congress
Evaluation of the Discrimination of 13 Mortality Risk Scores after Heart Transplantation in a Contemporary UNOS Cohort
G. Coutance, J. Patel, E. Kransdorf, R. Levine, E. Passano, J. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Multiple pre-transplant scores aimed at stratifying the risk of death or allograft loss after heart transplantation have been developed over time but their use…
2020 American Transplant Congress
Prognostic Index of Circulating Tumor Cells for Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
M. Chen¹, Z. Chen¹, X. Lin², W. Ju¹, X. He¹
¹Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Division of General Surgery, The Eastern Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Liver transplantation (LT) is an effective option for hepatocellular carcinoma (HCC) and end-stage liver cirrhosis. However, organ shortage and tumor recurrence are the main…
2020 American Transplant Congress
Modelling Patient Outcomes after Listing for Deceased Donor Kidney Transplantation in the UK: A Novel Technique
M. Ibrahim¹, L. Mumford¹, R. Hogg¹, R. Johnson¹, M. Pearson², J. Forsythe³, C. Callaghan⁴
¹Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, United Kingdom, ²Winton Centre for Risk Evidence and Communication, Cambridge, United Kingdom, ³NHS Blood and Transplant, Bristol, United Kingdom, ⁴Renal, Guy's and St Thomas' NHS Trust, London, United Kingdom
*Purpose: Novel methods of data analysis and communication are needed to aid clinician and patient understanding of clinical outcomes. We aimed to demonstrate patient outcomes…
2020 American Transplant Congress
Using Artificial Intelligence Tools for Identification of High Risk Transplant Recipients for Focused Management
M. A. Schnitzler¹, C. Dagli², C. Canfield², N. Dzebisashvili³, C. Varma¹, D. Axelrod⁴, K. Lentine¹, R. Ouseph¹, H. Randall¹
¹Saint Louis University, St. Louis, MO, ²Missouri S&T, Rolla, MO, ³CareDx, Brisbane, CA, ⁴University of Iowa, Iowa City, IA
*Purpose: Resources for post-transplant patient monitoring are limited. Statistical stratification can facilitate focused attention on highest risk patients. We developed a monitoring tool for graft…
2020 American Transplant Congress
Cross-Validation of Performance-Based Frailty against Daily Step Count from Personal Activity Trackers – Refining Prehabilitation Tools in Liver Transplant Candidates
M. A. Hassan¹, M. A. Dunn¹, P. M. Bloomer¹, A. H. Gougol¹, M. Serper², D. R. Jorgensen¹, A. Duarte-Rojo¹
¹Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Department of Medicine, University of Pennsylvania, Philadelphia, PA
*Purpose: The AST proposed a toolkit to identify frailty in liver transplant (LT) candidates, including the liver frailty index (LFI) and 6-min walk test (6MWT).…
2020 American Transplant Congress
Dominant Negative Polymorphisms in TNFRSF13B are Associated with Poor Transplant Outcome
M. G. de Mattos-Barbosa¹, E. T. Luning Prak², E. Farkash³, J. L. Platt⁴, M. Cascalho⁴
¹Transplant Surgery, University of Michigan, Ann Arbor, MI, ²Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ³Pathology, University of Michigan, Ann Arbor, MI, ⁴Transplant Surgery and Microbiology and Immunology, University of Michigan, Ann Arbor, MI
*Purpose: Transmembrane Activator and CAML Interactor (TACI) is a highly polymorphic receptor that controls B cell activation and differentiation into antibody-secreting cells. Allelic variants of…